Cervomed announces positive results from the extension phase of its phase 2b clinical study of neflamapimod in patients with dementia with lewy bodies

A new batch of neflamapimod capsules led to increased plasma drug concentrations and demonstrated improvement (p

CRVO Ratings Summary

CRVO Quant Ranking